DNAPrint Genomics, Inc.
DNAG · OTC
12/31/2006 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 90.7% | 62.4% | 10.7% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 31% | 25.5% | 35.3% | 39.1% |
| R&D Expenses | $6 | $2 | $2 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$9 | -$7 | -$12 |
| Operating Expenses | -$8 | -$4 | -$3 | -$6 |
| Operating Income | -$9 | -$5 | $3 | $6 |
| % Margin | -364.5% | -365.5% | 424.4% | 878.6% |
| Other Income/Exp. Net | -$3 | -$5 | -$3 | -$6 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$9 | -$4 | -$8 |
| % Margin | -507.5% | -683.3% | -475.4% | -1,097.7% |
| EPS | -0.03 | -0.09 | -0.2 | -3.2 |
| % Growth | 66.7% | 55% | 93.8% | – |
| EPS Diluted | -0.03 | -0.09 | -0.2 | -3.2 |
| Weighted Avg Shares Out | 365 | 94 | 35 | 25 |
| Weighted Avg Shares Out Dil | 365 | 94 | 35 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$9 | -$2 | -$2 | -$5 |
| % Margin | -367% | -186.2% | -290.5% | -732% |